Enzon Announces Phillip M. Renfro Joins Board of Directors.BRIDGEWATER, N.J. -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that Phillip M. Renfro has been appointed to the Company's Board of Directors. Mr. Renfro is a partner at the law firm of Fulbright & Jaworski, L.L.P., one of the largest international law firms This list of the world's largest law firms by revenue is taken from The Lawyer and The American Lawyer and is ordered by 2006 revenue:[1]
San Antonio is the second most populous city in Texas, the third most populous metropolitan area in Texas, and is the seventh most populous city in the United States. As of the 2006 U.S. office. Mr. Renfro has participated in a wide variety of financing transactions, including public and private equity and debt offerings. In addition, he has extensive experience in mergers and acquisitions of public and private entities both in the United States and in various foreign jurisdictions. Mr. Renfro is also a frequent speaker on issues related to corporate governance Corporate Governance The relationship between all the stakeholders in a company. This includes the shareholders, directors, and management of a company, as defined by the corporate charter, bylaws, formal policy, and rule of law. standards and the Sarbanes-Oxley Act See SOX. . "The addition of Mr. Renfro deepens the expertise of Enzon's Board of Directors," said Jeffrey H. Buchalter, Enzon's chairman and chief executive officer. "His extensive background in strategic transactions and corporate governance will be particularly important as we evaluate future growth opportunities for Enzon." Prior to joining Fulbright & Jaworski, Mr. Renfro was Chief Executive Officer of Resco International, an international oilfield service company, and Vice President and General Counsel of Weatherford International, one of the largest international oilfield service companies The list of oilfield service companies includes companies that provide services to the petroleum exploration and production industry but that do not typically produce petroleum themselves. in the United States from 1977 to 1983. Mr. Renfro graduated from the University of Texas School of Law The University of Texas School of Law is an ABA-certified American law school located on The University of Texas at Austin campus. The law school has been in existence since the founding of the University in 1883. in 1971. He is currently the Chairman of the Board of Texstar National Bank in San Antonio, Texas. About Enzon Enzon Pharmaceuticals is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics to treat life-threatening diseases. The Company has developed or acquired a number of marketed products, including PEG-INTRON(R), marketed by Schering-Plough, and ABELCET(R), ONCASPAR(R), ADAGEN(R), and DEPOCYT(R), marketed in North America by Enzon's specialized sales force. Enzon's science-driven strategy includes an extensive drug development program that leverages the Company's macromolecular mac·ro·mol·e·cule n. A very large molecule, such as a polymer or protein, consisting of many smaller structural units linked together. Also called supermolecule. engineering technology platforms, including PEG modification and single-chain antibody (SCA (Single Connector Attachment) An 80-pin plug and socket used to connect peripherals. With a SCSI drive, it rolls three cables (power, data channel and ID configuration) into one connector for fast installation and removal. (R)) technologies. Internal research and development efforts are complemented by strategic transactions that provide access to additional marketed products and promising clinical compounds. Enzon has several drug candidates in various stages of development, independently and with partners. Further information about Enzon can be found on the Company's web site at www.enzon.com. All information in this press release is as of January 4, 2005 and the Company undertakes no duty to update this information. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion